Saffar J L, Leroux P
Département de Parodontologie, Faculté de Chirurgie Dentaire, Université Paris-V, Montrouge, France.
Bone. 1988;9(3):141-5. doi: 10.1016/8756-3282(88)90003-8.
The role of prostaglandins (PGs) in physiological remodeling has not yet been defined. The present study was undertaken to determine whether they intervene during the activation phase in a highly reproducible and synchronized model of bone remodeling. Indomethacin was employed to inhibit PG synthesis. This treatment throughout the entire activation period (4 days in this model) inhibited osteoclastic resorption completely. By modifying the treatment procedure, it appeared that PGs were operative mainly between the second and third day of activation. PGs did not seem to act on precursor recruitment, since off-bone osteoclasts (putatively inactive cells) were numerous in the treated groups. PGs might also be involved in osteoclast activity as the mean interface between osteoclasts and bone surface was reduced in the treated groups. However, indomethacin was unable to inhibit the remodeling sequence durably since a 6-day treatment resulted in a high profile of resorption. This suggests that factors other than PGs were responsible for activating resorption.
前列腺素(PGs)在生理重塑中的作用尚未明确。本研究旨在确定它们是否在高度可重复且同步的骨重塑模型的激活阶段发挥干预作用。使用吲哚美辛抑制PG合成。在整个激活期(此模型中为4天)进行该处理可完全抑制破骨细胞吸收。通过改变处理程序,似乎PGs主要在激活的第二天和第三天发挥作用。PGs似乎对前体细胞募集没有作用,因为处理组中脱骨破骨细胞(推测为无活性细胞)数量众多。PGs也可能参与破骨细胞活性,因为处理组中破骨细胞与骨表面之间的平均界面减少。然而,吲哚美辛无法持久抑制重塑序列,因为6天的处理导致了高吸收状态。这表明除PGs外的其他因素负责激活吸收。